N-Methyl-2-pyrrolidone
N-Methyl-2-pyrrolidone releases at Nexeo Solutions LLC rose from 5k lb to 36k lb (7.8×) between 2023 and 2024.
Total reported releases 2.2M lb held roughly steady year over year (-5%). Total releases concentrations have more than doubled since 2015.
3930 GLENWOOD DR, Charlotte, North Carolina · 424690 · Chemical Wholesalers · operated by Univar Solutions USA INC
N-Methyl-2-pyrrolidone releases at Nexeo Solutions LLC rose from 5k lb to 36k lb (7.8×) between 2023 and 2024.
Xylene (mixed isomers) releases at Nexeo Solutions LLC rose from 254k lb to 478k lb between 2023 and 2024.
Methanol releases at Nexeo Solutions LLC fell from 553k lb to 274k lb (50% lower) between 2023 and 2024.
Toluene concentrations have more than doubled since 2015.
Xylene (mixed isomers) concentrations have more than doubled since 2015.
Methanol concentrations have more than doubled since 2015.
Methyl isobutyl ketone concentrations are up 43% since 2015.
n-Butyl alcohol concentrations are up 34% since 2015.
n-Hexane concentrations have more than doubled since 2021.
Certain glycol ethers concentrations have more than doubled since 2023.
N-Methyl-2-pyrrolidone concentrations have more than doubled since 2023.
Within 3 miles of this facility (56 Census block groups, population-weighted demographics): a population of 73,758. Why we surface this →
Low-income
People of color
Under age 5
Over age 64
Source: Census ACS 2018-2022 block-group demographics, population-weighted across the 3-mile buffer around this facility (from USEPA-clone/EJAM-open blockgroupstats). Indicator-level percentile and EJ-disparity scores are surfaced on the county page and the state page — they describe wider regional exposure burdens, not effects attributable to a single facility.
Source. EPA Toxics Release Inventory · retrieved 2026-05-07. Reporting year 2024. TRI is a federal public-domain dataset under 17 USC §105.
What this is not. TRI quantifies releases reported by the facility under EPCRA §313 — not ambient air or water concentrations measured at receptors. We do not attribute individual health outcomes to specific facilities; that exceeds what the data can support.